 |
Annual CTSI Regional Shared Mentoring Symposium - Virtual Event
Dec. 10, 2021, 8:30 am - 12:30 pm.
Register before Dec. 1, 2021
This symposium provides networking, panel discussions and one-to-one mentoring with senior faculty from local clinical and translational science institutions. Learn More
|
Program for Early Research Career Development (PERC) - Spring 2022
Application Deadline: Dec. 10, 2021
The PERC Program will provide a roadmap and targeted guidance for senior post-doctoral fellows and early career faculty (both MD and PhD) committed to launching an independent research career. Learn More
|
The BU CTSI Voucher Program
Applications are Accepted on a Rolling Basis.
The Voucher Program supports the short-term needs of research investigators that are not otherwise covered by grants. Vouchers are intended to enable preliminary work, generate data for new or ongoing projects, and/or secure fee-based core services for expert consultation services. Learn More
|
|
|
|
|
Funding & Fellowship Opportunities |
|
|
|
|
NIH HEAL Initiative: Preventing Opioid Misuse and Co-Occurring Conditions by Intervening on Social Determinants (R01 Clinical Trials Optional)
National Institute on Drug Abuse (NIDA)
|
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
|
HEAL Initiative: Developing Quantitative Imaging and Other Relevant Biomarkers of Myofascial Tissues for Clinical Pain Management (R61/R33, Clinical Trial Required)
National Center for Complementary and Integrative Health (NCCIH)
|
|
|
|
Notice of Special Interest: Administrative Supplements for Summer Research Experiences for Students and Science Teachers
National Institute of Environmental Health Sciences (NIEHS)
|
NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)
National Cancer Institute (NCI)
|
Notice of Special Interest (NOSI): Heart, Lung, Blood and Sleep Focused Ancillary Studies to Large Ongoing Clinical Studies (Revised)
National Heart, Lung, and Blood Institute (NHLBI)
|
|
|
|
Data Harmonization, Curation and Secondary Analysis of Existing Clinical Datasets (R61/R33 Clinical Trial Not Allowed)
Notice of Special Interest: SBIR Technology Transfer (R43/R44 Clinical Trial Not Allowed)
Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)
National Institute of Neurological Disorders and Stroke (NINDS)
|
NEI Regenerative Medicine Clinical Trial Planning Grant (R34 - Clinical Trials Not Allowed)
National Eye Institute (NEI)
|
|
|
|
|
Lung Autopsies of COVID-19 Patients Reveal Treatment Clues
The findings include details about how SARS-CoV-2 spreads in the lungs, manipulates the immune system, causes widespread thrombosis that does not resolve, and targets signaling pathways that promote lung failure, fibrosis and impair tissue repair. Read More
|
|
|
|
|
New Clues to Delta Variant’s Spread in Studies of Virus-Like Particles
It turns out that a specific mutation found within the N protein coding region of the Delta genome also enables the virus to pack more of its RNA code into the infected host cell. As a result, there is increased production of fully functional new viral particles. Read More
|
|
|
|
|
Early Data Suggest Pfizer Pill May Prevent Severe COVID-19
Over the course of this pandemic, significant progress has been made in treating COVID-19 and helping to save lives. That progress includes the development of life-preserving monoclonal antibody infusions. Read More
|
|
|
|
|
Using Lessons Learned from COVID-19 to Prepare for the Next Influenza Pandemic
Influenza remains the pathogen most likely to cause the next pandemic, and estimates say it could be more devastating than the ongoing COVID-19 pandemic. Read More
|
|
|
|
|
Biosketch 101:
Getting (Grant Reviewers) to Know You
Dec. 7, 2021, 3 - 4:30 pm
In this session, we will discuss how to make your experience and expertise shine through in the Personal Statement and Contributions to Science sections of the biosketch. Learn More
|
|
|
|
|
Navigating the Evolving Treatment Landscape for HP-Positive Breast Cancer
Dec. 8, 2021, 8:30 - 10:30 pm
During this live symposium, experts in the management of HR+/HER2− breast cancer will lead an interactive, case-based discussion on advancing the treatment of this tumor subtype. Learn More
|
|
|
|
|
Turning Your Good Manuscript Into
a Great Publication
Jan. 19, 2022, 3 - 4:30 pm
Reviewers ask you to adopt their favorite theoretical framework, redo the data analysis, write the paper they want to read, and add lots of new material, all despite the editor’s demand to make it 500 words shorter. Learn More
|
|
|
|
|
The Funding Acknowledgement |
|
|
|
|
The Funding Acknowledgement guides recipients of BU CTSI services, resources, or funding for projects or research through the grant citation process. All recipients are required to cite our grant number in associated presentations and journal publications.
|
|
|
|
|
|
|
|
|
